Effect of hydromorphone combined with ropivacaine sacral block on immune function after hypospadias in children

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300072599

Enrollment

Unknown

Registered

2023-06-19

Start date

2023-06-20

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypospadias

Interventions

Experimental group: hydromorphone combined with ropivacaine sacral block

Control group:ropivacaine sacral block

Eligibility

Sex/Gender

Male

Age

1 Years to 3 Years

Inclusion criteria

Inclusion criteria: Children with hypospadias: 1-3 years old, no gender limitation; ?ASA GRADE I ~ II; ? Children undergoing elective surgery under general anesthesia combined with sacral canal block.

Exclusion criteria

Exclusion criteria: ? Children with severe hypovolemia and shock. ? Children with abnormal platelet number function or abnormal coagulation function. ? Children with infection at the puncture site. ? Patients with central nervous system diseases, especially spinal. ? The child suffers from acute or severe bronchial asthma.

Design outcomes

Primary

Measure	Time frame
T cell subsets;	—

Secondary

Measure	Time frame
heart rate;blood pressure;	—

Countries

CHINA

Contacts

Public ContactCAI Yuzhu

Anhui Children's Hospital

237623107@qq.com+86 138 6617 8850

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026